Nucleos(t)ide withdrawal vs Nucleos(t)ide withdrawal with adjuvant pegylated-interferon in HBeAg-negative hepatitis B virus infection (NUC-B Trial).

Saved in:
Bibliographic Details
Title: Nucleos(t)ide withdrawal vs Nucleos(t)ide withdrawal with adjuvant pegylated-interferon in HBeAg-negative hepatitis B virus infection (NUC-B Trial).
Authors: Thursz M; Division of Digestive Diseases, Department of Metabolism, Digestion & Reproduction, Imperial College, London, UK., Lemoine M; Division of Digestive Diseases, Department of Metabolism, Digestion & Reproduction, Imperial College, London, UK., Brown A; Hepatology Department, Imperial College Healthcare NHS Trust, London, UK., Carey I; Institute of Liver Studies, King's College Hospital NHS Foundation Trust, London, UK., Message J; Imperial Clinical Trials Unit, School of Public Health, Imperial College, London, UK., Kennedy P; Liver Centre, Blizard Institute, Barts and The London School of Medicine and Dentistry, London, UK., Forton D; Hepatology, St George's University Hospitals NHS Foundation Trust, London, UK., Wiselka M; University Hospitals of Leicester NHS Trust, Leicester, UK., Aldersley M; Leeds Teaching Hospitals Trust, Leeds General Infirmary, Great George St, Leeds, LS1 3EX, UK., Prince M; Manchester Royal Infirmary, Manchester, UK., McPherson S; Hepatology, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK., Phillips S; The Roger Williams Institute of Liver Studies, School of Immunology and Microbial Sciences, Faculty of Life Sciences and Medicine, King's College London & Foundation for Liver Research, London, UK., Chokshi S; Institute of Hepatology Foundation for Liver Research London UK, School of Immunology and Microbial Sciences King's College London, London, UK., Burton A; The Babraham Institute, The University of Cambridge, UK., Maini M; Division of Infection and Immunity, Institute of Immunity and Transplantation, University College London, London, UK., Christiaan Botha J; Great Ormond Street Institute of Child Health, University College London, London, UK, and Advanced Pathogen Diagnostics Unit, University College London Hospitals NHS Trust, London, UK., Nastouli E; Department of Virology, UCLH, London, UK., Tsao S; Patient representative., Falaschetti E; Imperial Clinical Trials Unit, School of Public Health, Imperial College, London, UK., Box H; Imperial Clinical Trials Unit, School of Public Health, Imperial College, London, UK., Habib M; Imperial Clinical Trials Unit, School of Public Health, Imperial College, London, UK., Agarwal K; Institute of Liver Studies, King's College Hospital NHS Foundation Trust, London, UK.
Corporate Authors: NUC-B Study Group
Source: Hepatology (Baltimore, Md.) [Hepatology] 2026 Aug 04. Date of Electronic Publication: 2026 Aug 04.
Publication Type: Journal Article
Journal Info: Publisher: Wolters Kluwer Health, Inc Country of Publication: United States NLM ID: 8302946 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-3350 (Electronic) Linking ISSN: 02709139 NLM ISO Abbreviation: Hepatology Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1527-3350
DOI:10.1097/HEP.0000000000001821